Summary & Overview
HCPCS A9156: Oral Mucoadhesive, Per 1 ml
HCPCS Level II code A9156 identifies an oral mucoadhesive product (liquid, gel, paste, etc.) billed per 1 ml. These formulations are used to deliver topical therapy directly to the oral mucosa for conditions such as ulcers, mucositis, and localized irritation. At a national level, coverage and reimbursement for dispensed topical oral agents affect outpatient dental, oral surgery, and ambulatory clinical workflows and pharmacy sourcing.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for mucoadhesive oral products, common billing considerations tied to per-milliliter supply reporting, and what to expect when submitting claims to major commercial payers and Medicare. The publication summarizes typical sites of service, common modifiers that may appear on claims (list provided separately), and notes on data availability.
This summary provides benchmarks for how A9156 is used in practice, highlights policy and coverage themes relevant to outpatient and dental settings, and flags areas where data are not available in the input. Data not available in the input include specific associated taxonomies, ICD-10 diagnoses, related codes, and detailed payer-specific reimbursement rates.
Billing Code Overview
HCPCS Level II code A9156 describes an oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml. This item is a topical formulation designed to adhere to the oral mucosa for local treatment or symptomatic relief of oral lesions, ulcers, or mucosal irritation.
-
Service type: Topical oral medication delivery (mucoadhesive formulation)
-
Typical site of service: Dental offices, outpatient clinics, oral surgery settings, and other ambulatory care locations where topical management of oral mucosal conditions is provided.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient presenting with painful oral mucosal lesions (for example, chemotherapy- or radiation-induced oral mucositis, aphthous ulcers, oral lichen planus flare, or mucosal injury from trauma) requiring localized topical therapy. The clinician (often a dentist, oral surgeon, ENT specialist, oncologist, or primary care provider) evaluates the oral cavity, documents lesion location, size, severity, pain level, and prior treatments. When topical mucoadhesive therapy is indicated, the provider prescribes or administers an oral mucoadhesive formulation (liquid, gel, paste) and documents the volume used in milliliters for billing as A9156 per 1 ml. Typical workflow steps include assessment, informed consent (if needed), selection of product and dose, application (in-office direct application or dispensing with administration instructions), and documentation of clinical response and follow-up plan. Common sites of service include outpatient clinic, dental office, oncology infusion center, and ambulatory surgical centers for cases associated with procedural mucosal injury.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to provide the oral mucoadhesive is substantially greater than typically required (e.g., extensive debridement and application under difficult access). |